Pluri Inc. Proceeds from Issuance or Sale of Equity
Pluri Inc. (PLUR) reported Proceeds from Issuance or Sale of Equity of $34.11 million for the 1-month period ending 2012-09-30, per its 10-Q filed 2013-05-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2013-05-08
- 2012-09-30: Proceeds from Issuance or Sale of Equity 1 month $34.11M.
- 2012-09-19: Proceeds from Issuance or Sale of Equity 0 month $34.11K.
| Period end | Proceeds from Issuance or Sale of Equity 0 month | Proceeds from Issuance or Sale of Equity 1 month |
|---|---|---|
| 2012-09-30 | $34.11M 10-Q · filed 2013-05-08 | |
| 2012-09-19 | $34.11K 10-Q · filed 2013-01-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |